• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G filed by Genworth Financial Inc

    10/25/24 3:16:06 PM ET
    $GNW
    Life Insurance
    Finance
    Get the next $GNW alert in real time by email
    SC 13G 1 genworth3Q2024.txt 13-G FILING 3Q 2024 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. ___*) Genworth Financial Inc. (Name of Issuer) Common (Title of Class of Securities) 37247D106 (CUSIP Number) September 30, 2024 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [X ] Rule 13d-1(b) [ ] Rule 13d-1(c) [ ] Rule 13d-1(d) *The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). CUSIP No. 37247D106 1. Names of Reporting Persons. I.R.S. Identification Nos. of above persons (entities only). Donald Smith & Co., Inc. 13-2807845 2. Check the Appropriate Box if a Member of a Group (See Instructions) (a) (b) [X] 3. SEC Use Only ......................................................... 4. Citizenship or Place of Organization A Delaware Corporation Number of 5. Sole Voting Power 24,545,380 shares Shares Beneficially 6. Shared Voting Power 0 Owned by Each Reporting 7. Sole Dispositive Power 24,796,280shares Person With 8. Shared Dispositive Power 0 9.Aggregate Amount Beneficially Owned by Each Reporting Person 25,015,294 shares 10. Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) 11. Percent of Class Represented by Amount in Row (9) 5.79% 12. Type of Reporting Person (See Instructions) IA 1. Names of Reporting Persons. I.R.S. Identification Nos. of above persons (entities only). DSCO Value Fund, L.P. 27-1481102 2. Check the Appropriate Box if a Member of a Group (See Instructions) (a) (b) [X] 3. SEC Use Only ......................................................... 4. Citizenship or Place of Organization A Delaware Corporation Number of 5. Sole Voting Power 219,014 shares Shares Beneficially 6. Shared Voting Power 0 Owned by Each Reporting 7. Sole Dispositive Power 219,014 shares Person With 8. Shared Dispositive Power 0 9.Aggregate Amount Beneficially Owned by Each Reporting Person 25,015,294 shares 10. Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) 11. Percent of Class Represented by Amount in Row (9) 5.79% 12. Type of Reporting Person (See Instructions) PN Item 1. (a) Name of Issuer: Genworth Financial Inc. (b) Address of Issuer's Principal Executive Offices 11011 West Broad Street Glen Allen, VA 23060 Item 2. (a) Name of Person Filing: Donald Smith & Co.,Inc. (b) Address of Principal Business Office: 152 West 57th Street New York, NY 10019 (c) Citizenship: A Delaware Corporation (d) Title of Class of Securities: Common (e) CUSIP Number: 37247D106 Item 3. This statement is filed pursuant to Section 240.13d-1(b), and the person filing is an investment advisor registered in accordance with Section 240.13d-1(b)(1)(ii)(E); Item 4. Ownership. Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1. (a) Amount beneficially owned: 25,015,294 (b) Percent of class: 5.79% (c) Number of shares as to which the person has: (i) SOLE POWER TO VOTE: Donald Smith & Co., Inc. 24,545,380 DSCO Value Fund, L.P. 219,014 (ii) SHARED POWER TO VOTE: SEE ITEM 6 (iii) SOLE POWER TO DISPOSE: Donald Smith & Co., Inc. 24,796,280 DSCO Value Fund, L.P. 219,014 Item 5. Ownership of Five Percent or Less is NOT APPLICABLE Item 6. Ownership of More than Five Percent on Behalf of Another Person: 1. Donald Smith & Co., Inc. does not serve as custodian of the assets of any of its clients; accordingly, in each instance only the client or the client?s custodian or trustee bank has the right to receive dividends paid with respect to, and proceeds from the sale of, such securities. The ultimate power to direct the receipt of dividends paid with respect to, and the proceeds from the sale of, such securities, is vested in the institutional clients which Donald Smith & Co., Inc. serves as investment advisor. Any and all discretionary authority which has been delegated to Donald Smith & Co., Inc. may be revoked in whole or in part at any time. To the knowledge of Donald Smith & Co., Inc., with respect to all securities reported in this schedule owned by advisory clients of Donald Smith & Co., Inc., not more than 5% of the class of such securities is owned by any one client. 2. With respect to the remaining securities owned, various persons have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the Common Stock of Genworth Financial Inc. No one person?s interest in the Common Stock of Genworth Financial Inc. is more than five percent of the total outstanding Common Stock. Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company NOT APPLICABLE Item 8. Identification and Classification of Members of the Group See EXHIBIT A Item 9. Notice of Dissolution of Group NOT APPLICABLE Item 10. Certification (a) By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect. SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. October 22, 2024 Date Richard L. Greenberg___________ Signature CEO & Co-CIO_________________ Title SCHEDULE 13G - TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULE 13d-1(b) or 13d-2(b) RULE 13d-1(f)(1) EXHIBIT A: Donald Smith & Co., Inc. IA DSCO Value Fund, L.P. PN SCHEDULE 13G - TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULE 13d-1(b) or 13d-2(b) RULE 13d-1(f)(1) AGREEMENT The undersigned persons, on October 22, 2024, agree and consent to the joint filing on their behalf of this Schedule 13G in connection with their beneficial ownership of the Common Stock of Genworth Financial Inc. at September 30, 2024. Donald Smith & Co., Inc. By /s/ Richard L. Greenberg Richard L. Greenberg CEO & Co-CIO Duly authorized by and on behalf of Donald Smith & Co., Inc. DSCO Value Fund, L.P. By /s/ Richard L. Greenberg Richard L. Greenberg CEO & Co-CIO Duly authorized by and on behalf of DSCO Value Fund, L.P
    Get the next $GNW alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $GNW

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $GNW
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G filed by Genworth Financial Inc

      SC 13G - GENWORTH FINANCIAL INC (0001276520) (Subject)

      10/25/24 3:16:06 PM ET
      $GNW
      Life Insurance
      Finance
    • SEC Form SC 13G/A filed by Genworth Financial Inc (Amendment)

      SC 13G/A - GENWORTH FINANCIAL INC (0001276520) (Subject)

      2/13/24 5:06:12 PM ET
      $GNW
      Life Insurance
      Finance
    • SEC Form SC 13G filed by Genworth Financial Inc

      SC 13G - GENWORTH FINANCIAL INC (0001276520) (Subject)

      2/9/24 9:59:00 AM ET
      $GNW
      Life Insurance
      Finance

    $GNW
    Leadership Updates

    Live Leadership Updates

    See more
    • CareScout, a Genworth Company, Aims to Redefine Quality and Build Trust in Long-Term Care

      CareScout Quality Network brings together providers committed to person-centered care. CareScout today introduced the CareScout Quality Network, a first-of-its-kind group of long-term care providers who meet high standards for quality, person-centered care. "The long-term care industry is ripe for innovation because health and social systems aren't built to support the demand of our rapidly aging population. Older adults and their families are left to navigate a fragmented and confusing experience to find care," said Samir Shah, CEO of CareScout Services. "Quality measures today only meet the lowest common denominator of patient safety, which is important, but provides zero insight into

      2/13/24 8:30:00 AM ET
      $GNW
      Life Insurance
      Finance
    • Genworth And Oceanwide Provide Transaction Update; Genworth To Focus on Contingency Plan

      RICHMOND, Va., Jan. 4, 2021 /PRNewswire/ -- Genworth Financial, Inc. (NYSE: GNW) (Genworth, the Company) and China Oceanwide Holdings Group Co., Ltd. (Oceanwide) today provided an update on their pending transaction. Given uncertainty around the completion and timing of the remaining steps required to close the transaction, Genworth and Oceanwide have not extended the current December 31, 2020 "end date" under the merger agreement. Oceanwide has indicated that the factors contributing to the delay since the parties agreed to their most recent extension of the merger agreement on November 30, 2020 were: (a) the finalization of the Hony Capital financing terms; and (b) the COVID-19 pandemi

      1/4/21 7:00:00 AM ET
      $GNW
      Life Insurance
      Finance

    $GNW
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Genworth Financial Announces Results of Annual Meeting

      Genworth Financial, Inc. (NYSE:GNW) announced the election of all ten director nominees at its 2025 annual meeting of stockholders today. The board members re-elected were G. Kent Conrad, Karen E. Dyson, Jill R. Goodman, Melina E. Higgins, Thomas J. McInerney, Howard D. Mills, III, Robert P. Restrepo Jr., Elaine A. Sarsynski, Ramsey D. Smith, and Steven C. Van Wyk. At the annual meeting, stockholders also approved the advisory vote on named executive officer compensation and the 2025 Omnibus Incentive Plan. In addition, stockholders ratified the selection of KPMG LLP as Genworth's independent registered public accounting firm for 2025. In addition, stockholders approved an amendment to th

      5/22/25 1:32:00 PM ET
      $ACT
      $GNW
      Specialty Insurers
      Finance
      Life Insurance
    • Genworth Financial Announces First Quarter 2025 Results

      Strategic Highlights Executed $45M in share repurchases at an average price of $6.91 per share; $590M program-to-date through March 31, 2025 at an average price of $5.73 per share Continued progress on the LTC1 multi-year rate action plan with $24M of gross incremental premium approvals; approximately $31.3B estimated net present value achieved since 2012 from in-force rate actions (IFAs) Strong progress made towards the expansion of the CareScout Quality Network, growing coverage to 90% of the aged 65-plus census population in the United States and delivered 576 matches in the first quarter Financial Highlights Net income2 of $54M, or $0.13 per diluted share, and adjusted operati

      4/30/25 4:15:00 PM ET
      $ACT
      $GNW
      Specialty Insurers
      Finance
      Life Insurance
    • Genworth Financial Schedules Earnings Conference Call for May 1

      Genworth Financial, Inc. (NYSE:GNW) today announced it will issue its earnings release containing first quarter results after the market closes on April 30, 2025. A conference call will be held on May 1, 2025, at 10:00 a.m. (ET) to discuss the quarter's results. Genworth's earnings release, summary presentation and financial supplement will be available through the company's website, http://investor.genworth.com, at the time of their release to the public. Genworth's conference call will be accessible via telephone and internet. The dial-in number for Genworth's May 1 conference call is 888-208-1820 or 323-794-2110 (outside the U.S.); conference ID #3161071. To participate in the call by

      4/10/25 4:15:00 PM ET
      $ACT
      $GNW
      Specialty Insurers
      Finance
      Life Insurance

    $GNW
    SEC Filings

    See more
    • SEC Form 8-K filed by Genworth Financial Inc

      8-K - GENWORTH FINANCIAL INC (0001276520) (Filer)

      5/22/25 4:16:10 PM ET
      $GNW
      Life Insurance
      Finance
    • SEC Form SCHEDULE 13G filed by Genworth Financial Inc

      SCHEDULE 13G - GENWORTH FINANCIAL INC (0001276520) (Subject)

      5/13/25 4:01:16 PM ET
      $GNW
      Life Insurance
      Finance
    • SEC Form 10-Q filed by Genworth Financial Inc

      10-Q - GENWORTH FINANCIAL INC (0001276520) (Filer)

      5/2/25 6:31:11 AM ET
      $GNW
      Life Insurance
      Finance

    $GNW
    Financials

    Live finance-specific insights

    See more
    • Genworth Financial Announces First Quarter 2025 Results

      Strategic Highlights Executed $45M in share repurchases at an average price of $6.91 per share; $590M program-to-date through March 31, 2025 at an average price of $5.73 per share Continued progress on the LTC1 multi-year rate action plan with $24M of gross incremental premium approvals; approximately $31.3B estimated net present value achieved since 2012 from in-force rate actions (IFAs) Strong progress made towards the expansion of the CareScout Quality Network, growing coverage to 90% of the aged 65-plus census population in the United States and delivered 576 matches in the first quarter Financial Highlights Net income2 of $54M, or $0.13 per diluted share, and adjusted operati

      4/30/25 4:15:00 PM ET
      $ACT
      $GNW
      Specialty Insurers
      Finance
      Life Insurance
    • Genworth Financial Schedules Earnings Conference Call for May 1

      Genworth Financial, Inc. (NYSE:GNW) today announced it will issue its earnings release containing first quarter results after the market closes on April 30, 2025. A conference call will be held on May 1, 2025, at 10:00 a.m. (ET) to discuss the quarter's results. Genworth's earnings release, summary presentation and financial supplement will be available through the company's website, http://investor.genworth.com, at the time of their release to the public. Genworth's conference call will be accessible via telephone and internet. The dial-in number for Genworth's May 1 conference call is 888-208-1820 or 323-794-2110 (outside the U.S.); conference ID #3161071. To participate in the call by

      4/10/25 4:15:00 PM ET
      $ACT
      $GNW
      Specialty Insurers
      Finance
      Life Insurance
    • Genworth Financial Announces Fourth Quarter 2024 Results

      Strategic Highlights Expanded the CareScout Quality Network to all 50 states, covering over 86% of the aged 65-plus census population in the United States Continued progress on the LTC1 multi-year rate action plan with $40M of gross incremental premium approvals; approximately $31.2B estimated net present value achieved since 2012 from in-force rate actions (IFAs) Executed $51M in share repurchases in the quarter at an average price of $7.32 per share; $186M executed in 2024 at an average price of $6.52 per share; $565M in share repurchases program-to-date through February 14th at an average price of $5.69 per share Repurchased $31M in principal of holding company debt at a discount

      2/18/25 4:15:00 PM ET
      $ACT
      $GNW
      Specialty Insurers
      Finance
      Life Insurance

    $GNW
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Van Wyk Steven C. was granted 45,576 shares (SEC Form 4)

      4 - GENWORTH FINANCIAL INC (0001276520) (Issuer)

      5/23/25 4:24:22 PM ET
      $GNW
      Life Insurance
      Finance
    • Director Smith Ramsey D. was granted 23,681 shares, increasing direct ownership by 47% to 74,391 units (SEC Form 4)

      4 - GENWORTH FINANCIAL INC (0001276520) (Issuer)

      5/23/25 4:24:07 PM ET
      $GNW
      Life Insurance
      Finance
    • Director Sarsynski Elaine A was granted 41,622 shares, increasing direct ownership by 46% to 132,899 units (SEC Form 4)

      4 - GENWORTH FINANCIAL INC (0001276520) (Issuer)

      5/23/25 4:23:47 PM ET
      $GNW
      Life Insurance
      Finance